Z-Medica, LLC, a leading developer and marketer of hemostatic devices based in Wallingford, reports that its QuikClot® Control+™ has been cleared for use by the FDA under the de novo classification process and is designated as a Class II medical device.

QuikClot Control+ is indicated for temporary control of internal organ space bleeding for patients displaying class III or class IV bleeding. It may also be used for control of severely bleeding wounds such as surgical wounds and traumatic injuries.